Therapeutic Solutions International, Inc. (TSOI)

Market Cap	7.05K -99.0%
Revenue (ttm)	85.32K +1.9%
Net Income	-2.41M
EPS	-0.00
Shares Out	7.05B
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	262,500
Open	0.0001
Previous Close	0.0001
Day's Range	0.0001 - 0.0001
52-Week Range	0.000001 - 0.0001
Beta	0.22
Analysts	n/a
Price Target	n/a
Earnings Date	Mar 27, 2026

About TSOI

Therapeutic Solutions International, Inc. focuses on immune modulation for the treatment of various specific diseases in the United States. The company develops a range of immune-modulatory agents to cancers, schizophrenia, suicidal ideation, and traumatic brain injury, as well as for daily health. Its flagship products consist of QuadraMune, a patented synergistic blend of pterostilbene, sulforaphane, epigallocatechingallate, and thymoquionone to increase natural killer cell activity and healthy cytokine production. The company also produces n...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2007
• Employees: 3
• Stock Exchange: OTCMKTS
• Ticker Symbol: TSOI

Financial Performance

In 2023, TSOI's revenue was $98,994, a decrease of -52.12% compared to the previous year's $206,767. Losses were -$2.17 million, -43.11% less than in 2022.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Aug 20, 2026

Data Sources Report a data error